Investigation Launched Against DocGo Inc. for Allegations

New Orleans, LA – An investigation led by former Louisiana Attorney General Charles C. Foti, Jr. is currently examining allegations against DocGo Inc., a healthcare firm known for providing medical transportation and mobile health services in the U.S. and the U.K. The inquiry is being conducted by Kahn Swick & Foti, LLC (KSF), a prominent securities litigation law firm.

The investigation was initiated following allegations that arose in September 2023, concerning DocGo’s purported misrepresentations regarding a significant contract with U.S. Customs and Border Protection (CBP). The company had claimed the CBP contract was valued at $4 billion. However, subsequent reports indicated that the actual contract value is less than $2 billion. This discrepancy has raised questions about the company’s transparency and the accuracy of its financial disclosures.

Additionally, claims have surfaced regarding the company’s Chief Executive Officer, who allegedly fabricated details of his educational background. This controversy led to his resignation, further compounding concerns for investors and stakeholders connected to DocGo.

In response to these allegations, a securities class action lawsuit has been filed against DocGo and its executives. The suit contends that the company and its leadership failed to disclose critical information that could influence investor decisions, citing violations of federal securities laws. A recent court ruling has denied the company’s motion to dismiss the lawsuit, permitting it to proceed through the judicial process. This development underscores the serious nature of the allegations against DocGo and its management.

As part of the ongoing investigation, KSF is assessing whether DocGo’s officers or directors acted in violation of their fiduciary duties or breached state or federal laws. Stakeholders with information pertaining to the inquiry or those who have held shares in DocGo for an extended period are encouraged to reach out to KSF for further assistance regarding their legal rights and any potential claims they may have.

Founded in 2009, DocGo specializes in delivering a range of healthcare solutions rooted in mobile health and has established itself across various regions. However, the recent controversies have raised serious questions about the company’s integrity and the trust of its investors, which may have broader implications for its business practices and future viability.

Over the years, DocGo has worked closely with government agencies and private entities, providing essential medical services that include transport for patients and emergency response capabilities. The company’s reputation and operational effectiveness may be jeopardized if the ongoing legal challenges reveal significant misconduct or inadequacies in their management structure.

The current investigation and litigation against DocGo highlight critical issues related to corporate governance transparency and accountability. As the legal proceedings unfold, stakeholders within the healthcare industry will likely watch closely, given the potential repercussions of the outcome and its impact on public trust in healthcare providers.

KSF, recognized for its extensive experience in securities litigation, operates multiple offices across the United States and remains committed to pursuing justice on behalf of affected investors. Individuals with pertinent information are urged to engage with KSF to contribute to the investigation and to better understand their legal standing in relation to this evolving situation.